Adverse effects following Covid 19 vaccination among students of a Private Medical College | [Rawal Medical Journal • 2024]

Author(s):

1. Shezadi Sabah Imran: Department of Community Medicine, Wah Medical College and National University of Medical Sciences,Rawalpindi,Pakistan

2. Musarat Ramzan: Department of Community Medicine, Wah Medical College and National University of Medical Sciences,Rawalpindi,Pakistan

3. Khola Waheed Khan: Department of Community Medicine, Wah Medical College and National University of Medical Sciences,Rawalpindi,Pakistan

4. Robina Mushtaq: Department of Community Medicine, Wah Medical College and National University of Medical Sciences,Rawalpindi,Pakistan

5. Sadia Nadeem: Department of Community Medicine, Wah Medical College and National University of Medical Sciences,Rawalpindi,Pakistan

Abstract:

Objective: To assess frequency of various side effects following covid vaccination among medical students and to determine association of gender and type of vaccines with the side effects. Methodology: This cross-sectional study was included 381 students at Wah Medical College, Wah Cantt and was conducted from 28th January to May 2023. We used convenient sampling technique and a questionnaire was used for data collection. SPSS version 23 was used for data analysis. Chi square test was applied on gender and type of vaccine with various adverse effects following vaccination. Results: Fever (32.3%), headache (28.1%) and body aches (26.8%) were the most common adverse effects following vaccination. There was significant association between type of vaccines with fever (p=0.001), loss of taste (p=0.003) and smell (p=0.045), shortness of breath (p=0.003), sore throat (p=0.007) chest pain (p=0.015) and hypertension (p=0.047). The loss of taste was reported more in males (p=0.006) while the swelling and tenderness at injection site were reported more common in females (p=0.000). Conclusion: Side effects were more related to the mRNA or viral vector vaccines.

Page(s): 1-4

DOI: DOI not available

Published: Journal: Rawal Medical Journal, Volume: 49, Issue: 4, Year: 2024

Keywords:

medical students , side effects , Crosssectional study , COVID 19 vaccines

References:

[1] Alamer E,Alhazmi A,Qasir NA,Alamer R,Areeshi H,Gohal G .2021 .Side effects of covid-19 pfizer-biontech mrna vaccine in children aged 12-18 years in Saudi Arabia. Vaccines, 9 : 1297-9.

[2] Hassine IH .2022 .Covid-19 vaccines and variants of concern: A review. Rev Med Virol, 32 : e2313.

[3] Siddique S,Ahmed S .2021 .Covid-19 vaccines in Pakistan: efficacy, adverse effects, and availability. J Islamabad Med Dental Coll, 10 : 125-30.

[4] Sprent J,King C .2021 .Covid-19 vaccine side effects: The positives about feeling bad. Sci Immunol, 6 : 256-9.

[5] Mathieu E,Ritchie H,Ortiz-Ospina E,Roser M,Hasell J,Appel C .2021 .A global database of COVID-19 vaccinations. Nat Hum Behav, 5 : 947-53.

[6] Abbas S,Abbas B,Amir S,Wajahat M .2021 .Evaluation of adverse effects with covid-19 vaccination in Pakistan. Pak J Med Sci, 37 : 1959-64.

[7] Meo SA,Bukhari IA,Akram J,Meo AS,Klonoff DC .2021 .COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines. Eur Rev Med Pharmacol Sci, 25 : 1663-9.

[8] Niebel D,Novak N,Wilhelmi J,Ziob J,Wilsmann-Theis D,Bieber T .2021 .Cutaneous adverse reactions to covid19 vaccines: Insights from an immuno-dermatological perspective. Vaccines, 9 : 944-8.

[9] Esba LCA,Al Jeraisy M. LCA .2021 .Reported adverse effects following covid-19 vaccination at a tertiary care hospital, focus on cerebral venous sinus thrombosis. Expert Rev Vaccines, 20 : 1037-42.

[10] Carli G,Nichele I,Ruggeri M,Barra S,Tosetto A .2021 .Deep vein thrombosis occurring shortly after the second dose of mRNA SARS-CoV-2 vaccine. Intern Emerg Med, 16 : 803-804.

[11] Dionne A,Sperotto F,Chamberlain S,Baker AL,Powell AJ,Prakash A .2021 .Association of myocarditis with BNT162b2 messenger RNA covid-19 vaccine in a case series of children. JAMA Cardiol, 6 : 1446-50.

[12] Oliver SE,Gargano JW,Marin M,Wallace M,Curran KG,Chamberland M,vaccine-United States .2020 .The advisory committee on immunization practices' interim recommendation for use of Pfizer-BioNTech COVID-. Morb Mortal Wkly Rep, 69 : 1922-4.

[13] Xia S,Duan K,Zhang Y,Zhao D,Zhang H,Xie Z .2020 .Effect of an inactivated vaccine against SARS-CoV-2 on safety and Immunogenicity outcomes: Interim analysis of 2 randomized clinical trials. J Am Med Assoc, 324 : 951-60.

[14] Riad A,Hocková B,Kantorová L,Slávik R,Spurná L,Stebel A .2021 .Side effects of mMRN-based covid-19 vaccine: Nationwide phase iv study among healthcare workers in slovakia. Pharmaceuticals, 14 : 873-5.

[15] Menni C,Klaser K,May A,Polidori L,Capdevila J,Louca P .2021 .Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the covid symptom study app in the UK: a prospective observational study. Lancet Infect Dis, 21 : 939-99.

[16] Folegatti PM,Ewer KJ,Aley PK,Angus B,Becker S,Belij-Rammerstorfer S .2020 .Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomized control trial. Lancet, 396 : 467-78.

[17] Mulligan MJ,Lyke KE,Kitchin N,Absalon K,Gurtman A,Lockhart S .2020 .Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults. Nature, 586 : 589-93.

[18] Flanagan KL,Fink AL,Plebanski M,Klein SL .2017 .Sex and gender differences in the outcomes of vaccination over the life course. Annu Rev Cell Dev Biol, 33 : 577-99.

[19] Frenck RW,Klein NP,Kitchin N,Gurtman A,Absalon J,Lockhart S .2021 .Safety, immunogenicity, and efficacy of the BNT162b2 Covid-19 vaccine in adolescents. N Engl J Med, 385 : 239-50.

[20] Mohammed RA,Garout RM,Wahid S,Ayub F,ZinAlddin LM,Sultan I. .2021 .A Survey on the Side Effects of Pfizer/BioNTech COVID-19 Vaccine Among Vaccinated Adults in Saudi Arabia. Cureus, 13 : e19222.

[21] Ossato A,Tessari R,Trabucchi C,Zuppini T,Realdon N,Marchesini F .2023 .Comparison of medium-term adverse reactions induced by the first and second dose of mRNA BNT162b2 (Comirnaty, Pfizer-BioNTech) vaccine: A post-marketing Italian study conducted between 1 January and 28 February 2021. Eur J Hosp Pharm, 30 : e15.

Citations

Downloads

Views